Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
Hypofractionated Brain Radiation In EGFR Mutated Adenocarcinoma Cranial Disease (Hybrid)
ClinicalTrials.gov study NCT02882984. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN2)
ClinicalTrials.gov study NCT06813365. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Osimertinib Monotherapy or Combination With Chemotherapy for Advanced NSCLC Concurrent EGFR and TP53 Mutations
ClinicalTrials.gov study NCT04695925. IPD Sharing: NO. Countries: 1. Publications: 0.
Dacomitinib Treatment Followed by 3rd Generation EGFR-TKI in Patients With EGFR Mutation Positive Advanced NSCLC
ClinicalTrials.gov study NCT04768491. IPD Sharing: NO. Countries: 1. Publications: 0.
Nimotuzumab in EGFR Highly Expressed Pancreatic Neuroendocrine Neoplasms
ClinicalTrials.gov study NCT05316480. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Osimertinib In EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT03586453. IPD Sharing: NO. Countries: 1. Publications: 0.
EGFR CART Cells for Patients With Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT03152435. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Irinotecan and Cetuximab Versus Irinotecan as Second-Line Treatment in Patients With Metastatic, EGFR-Positive Colorectal Cancer
ClinicalTrials.gov study NCT00063141. IPD Sharing: Not stated. Countries: 17. Publications: 0.
Glumetinib Combined With Osimertinib in the Treatment of Relapsed and Metastatic Non-small Cell Lung Cancer Patients Who Failed to Receive EGFR Inhibitors
ClinicalTrials.gov study NCT04338243. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
A Multinational Study Assessing an Oral EGFR Inhibitor, DZD6008 in Patients Who Have Advanced NSCLC With EGFR Mutations (TIAN-SHAN1)
ClinicalTrials.gov study NCT06905197. IPD Sharing: NO. Countries: 2. Publications: 0.
Osimertinib and Tegavivint as First-Line Therapy for the Treatment of Metastatic EGFR-Mutant Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT04780568. IPD Sharing: NO. Countries: 1. Publications: 0.
Osimertinib Combined With Anlotinib in EGFR T790M Mutated NSCLC Patients With Progression on Osimertinib Treatment
ClinicalTrials.gov study NCT04438902. IPD Sharing: NO. Countries: 1. Publications: 0.
Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients
ClinicalTrials.gov study NCT03236675. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Evaluation of 89Zr-DFO-nimotuzumab for Non-invasive Imaging of EGFR+ Cancers by Positron Emission Tomography (PET)
ClinicalTrials.gov study NCT04235114. IPD Sharing: NO. Countries: 1. Publications: 0.
A Dose Escalation Study of ASP8273 in Subjects With Non-Small-Cell Lung Cancer (NSCLC) Who Have Epidermal Growth Factor Receptor (EGFR) Mutations
ClinicalTrials.gov study NCT02113813. IPD Sharing: YES. Countries: 1. Publications: 0.
Study of BEBT-109 in Subjects With EGFR Exon 20 Insertion Mutations Non-Small Cell Lung Cancer
ClinicalTrials.gov study NCT06706713. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Observational Study to Characterize the Incidence of EGFR Mutation Positive and Advanced NSCLC Patients
ClinicalTrials.gov study NCT01717105. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of ORIC-114 in Patients With Advanced Solid Tumors Harboring an EGFR or HER2 Alteration
ClinicalTrials.gov study NCT05315700. IPD Sharing: NO. Countries: 10. Publications: 0.
Adjuvant Befotertinib in Stage IB-IIIB Non-small Cell Lung Cancer With Positive EGFR Sensitive Mutations
ClinicalTrials.gov study NCT06041776. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy of Cadonilimab in Non-squamous Non-small Cell Lung Cancer Patients Resistant to EGFR-TKI
ClinicalTrials.gov study NCT06277674. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.